NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Thursday it has been awarded a contract by the US Department of Defense to develop a prototype instrument for the rapid detection of biothreat agents and patient response biomarkers that may indicate systemic disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.